MedCap AB (Sweden) Insiders
| MCAP Stock | SEK 551.00 3.00 0.55% |
MedCap AB employs about 3 people. The company is managed by 3 executives with a total tenure of roughly 7 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Breaking down MedCap AB's management performance can provide insight into the firm performance.
| Lars ngman Insider Investment Mang |
| Kristina Ekblad Insider Chief Officer |
MedCap |
MedCap AB Management Team Effectiveness
The company has return on total asset (ROA) of 0.0822 % which means that it generated a profit of $0.0822 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1516 %, meaning that it generated $0.1516 on every $100 dollars invested by stockholders. MedCap AB's management efficiency ratios could be used to measure how well MedCap AB manages its routine affairs as well as how well it operates its assets and liabilities.MedCap AB Workforce Comparison
MedCap AB is considered to be number one stock in number of employees category among its peers. The total workforce of Asset Management industry is now estimated at about 2,031. MedCap AB adds roughly 3.0 in number of employees claiming only tiny portion of stocks in Asset Management industry.
The company has Profit Margin (PM) of 0.1 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.15 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.15. MedCap AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. MedCap AB Price Series Summation is a cross summation of MedCap AB price series and its benchmark/peer.
MedCap AB Notable Stakeholders
A MedCap AB stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as MedCap AB often face trade-offs trying to please all of them. MedCap AB's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting MedCap AB's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Lars ngman | Investment Mang | Profile | |
| Kristina Ekblad | Chief Officer | Profile | |
| Anders Dahlberg | Chief Officer | Profile |
About MedCap AB Management Performance
The success or failure of an entity such as MedCap AB often depends on how effective the management is. MedCap AB management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MedCap management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MedCap management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
MedCap AB is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, growth capital, middle market, mature, turnarounds, buyout. MedCap AB was founded in 2001 and is based in Stockholm, Sweden. MedCap AB operates under Medical Equipment classification in Sweden and is traded on Stockholm Stock Exchange.
Please note, the imprecision that can be found in MedCap AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MedCap AB. Check MedCap AB's Beneish M Score to see the likelihood of MedCap AB's management manipulating its earnings.
MedCap AB Workforce Analysis
Traditionally, organizations such as MedCap AB use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare MedCap AB within its industry.MedCap AB Manpower Efficiency
Return on MedCap AB Manpower
| Revenue Per Employee | 305.4M | |
| Revenue Per Executive | 305.4M | |
| Net Income Per Employee | 32.2M | |
| Net Income Per Executive | 32.2M | |
| Working Capital Per Employee | 47M | |
| Working Capital Per Executive | 47M |
Additional Tools for MedCap Stock Analysis
When running MedCap AB's price analysis, check to measure MedCap AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedCap AB is operating at the current time. Most of MedCap AB's value examination focuses on studying past and present price action to predict the probability of MedCap AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedCap AB's price. Additionally, you may evaluate how the addition of MedCap AB to your portfolios can decrease your overall portfolio volatility.